Phase 3 Low Anterior Resection Syndrome Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 2Phase 3
Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.
Radiotherapy Side EffectNeoadjuvant TherapyChemotherapy+8 more
National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos400 enrolled1 locationNCT06758830
Recruiting
Phase 3
Improving Functional Outcomes and Quality of Life in Patients With Rectal Cancer After Surgery With Intensified Follow-up & Surveillance
Quality of Life (QOL)Rectal CancerLARS - Low Anterior Resection Syndrome+1 more
University Hospital, Basel, Switzerland140 enrolled5 locationsNCT06936774
Recruiting
Phase 2Phase 3
Antegrade Intestinal Fluid Reinfusion for Prevention of Low Anterior Resection Syndrome After Low Anterior Resection: a Single-Center, Prospective Randomized Controlled Trial.
Rectal CancerLow Anterior Resection Syndrome
Pei-Rong Ding160 enrolled1 locationNCT07537998
Recruiting
Phase 3
Comparison of Transanal Irrigation and Glycerol Suppositories in Treatment of Low Anterior Resection Syndrome
Rectal CancerLow Anterior Resection Syndrome
University of Aarhus114 enrolled1 locationNCT04087421